Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1124261C details a Lewis acid-catalyzed route for polyene esters, offering significant cost reduction and supply chain reliability for high-purity carotenoid intermediate manufacturing.
This report analyzes patent CN114835577B for aldehyde synthesis. It offers cost reduction in pharmaceutical intermediates manufacturing and ensures supply chain reliability for global buyers.
Patent CN114920617B reveals a high-yield Lewis acid catalyzed route for polysubstituted naphthalenes, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel ticagrelor preparation method avoids hazardous chlorinating agents. Water-based steps reduce cost. Reliable supplier for scale-up and high purity.
Patent CN103570617A details a high-yield oxidation method for 3-cyano-pyridine N-oxide, offering superior purity for agrochemical and pharmaceutical supply chains.
Patent CN101633643A details a high-yield Boron trifluoride catalyzed synthesis of Ornidazole, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107033178B details a high-yield Lewis acid catalyzed route for trimethylsilyl enynes. Discover cost-effective supply chain solutions for complex organosilicon intermediates.
Patent CN112794794A reveals a high-yield one-pot synthesis for terphenyl macrocycles. Discover cost-effective supply chain solutions for advanced separation materials.
Novel patent CN115322110A offers a greener, scalable route for Eltrombopag intermediates, reducing toxic reagent reliance and enhancing supply chain stability for pharmaceutical manufacturers.
Discover a novel preparation method for Granisetron intermediate 3α-homotropylamine featuring mild conditions, high stereoselectivity, and cost-effective purification suitable for industrial scale-up.
Patent CN102056966A details a novel mixed catalyst process for polyaminopolyphenyl methanes, offering reduced impurities and extended catalyst life for cost-effective manufacturing.
Patent CN113896703A reveals a high-yield green synthesis of daidzein using BF3 and P2O5, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102199130A details a robust zinc-catalyzed route for chiral oxazoline, offering cost-effective solutions for reliable pharmaceutical intermediate suppliers.
Novel Lewis acid catalyzed route for benzo[e]indole intermediates. Reduces steps and enhances supply chain reliability for pharmaceutical manufacturing.
Discover the novel preparation of 2,2,6,6-tetraethyl-3,5-heptanedione using a catalytic Grignard approach. High purity >99% for NMR reagents and OLED applications.
Patent CN112645982A details a scalable synthesis of Remdesivir intermediate INT using Lewis acid catalysis and perfluorinated solvent extraction for superior purity and yield.
Patent CN109776506B details a novel 10-step synthesis of chiral (-)-cephalotaxine from furan. Discover cost-effective manufacturing and supply chain advantages.
Novel synthesis route for HCV intermediate reduces cost and improves purity for pharmaceutical supply chains. Efficient scalable production of high-purity antiviral drug intermediates ensures reliable global supply continuity.
Novel Lewis acid catalyzed reductive amination route offers >99% purity and scalable production for pharmaceutical intermediates.
Patent CN115724783A reveals a novel furfural-based route for asymmetric cyanine dyes, offering superior regioselectivity and cost reduction in biomedical material manufacturing.